OverviewSuggest Edit

Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease, or PAD. The Company manufactures and sells a suite of products including the Lightbox imaging console, as well as the Wildcat, Kittycat2, Ocelot family of catheters, and Pantheris. 

TypePublic
Founded2007
HQRedwood City, US
Websiteavinger.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Dec 2018)75(+16%)
Job Openings4
Revenue (FY, 2018)$7.9 M(-20%)
Share Price (Feb 2020)$0.7 (+3%)

Key People/Management at Avinger

Jeffrey M. Soinski

Jeffrey M. Soinski

Chief Executive Officer
Mark Weinswig

Mark Weinswig

Chief Financial Officer
Bunty Banerjee

Bunty Banerjee

SVP, Operations
Bart Beasley

Bart Beasley

VP, Marketing, Product Development
Thomas Lawson

Thomas Lawson

Vice President, Clinical & Regulatory Affairs
Jay Sundaram

Jay Sundaram

Vice President, Quality Management Representative
Show more

Avinger Office Locations

Avinger has an office in Redwood City
Redwood City, US (HQ)
600 Chesapeake Dr
Show all (1)

Avinger Financials and Metrics

Avinger Revenue

Embed Graph
View revenue for all periods
Avinger's revenue was reported to be $7.92 m in FY, 2018
USD

Revenue (Q3, 2019)

2.4m

Gross profit (Q3, 2019)

847.0k

Gross profit margin (Q3, 2019), %

35.1%

Net income (Q3, 2019)

(4.6m)

EBIT (Q3, 2019)

(4.6m)

Market capitalization (21-Feb-2020)

11.3m

Closing stock price (21-Feb-2020)

0.7

Cash (30-Sept-2019)

14.5m

EV

1.1m
Avinger's current market capitalization is $11.3 m.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

10.7m19.2m9.9m7.9m

Cost of goods sold

6.5m14.4m13.0m6.5m

Gross profit

4.2m4.8m(3.1m)1.4m

Gross profit Margin, %

40%25%(31%)17%
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

2.1m3.0m2.7m4.5m4.7m5.3m3.5m2.5m2.1m1.8m2.1m2.0m1.8m2.3m2.4m

Cost of goods sold

1.3m1.6m1.8m3.4m3.6m3.7m4.1m3.9m3.3m1.4m2.2m1.5m1.5m1.6m1.6m

Gross profit

800.0k1.4m971.0k1.2m1.0m1.6m(584.0k)(1.5m)(1.2m)394.0k(111.0k)543.0k373.0k720.0k847.0k

Gross profit Margin, %

38%46%36%26%22%30%(17%)(59%)(58%)22%(5%)27%20%31%35%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

43.1m36.1m5.4m16.4m

Accounts Receivable

1.6m1.1m1.2m

Prepaid Expenses

640.0k635.0k

Inventories

5.4m8.5m4.3m3.4m
Quarterly
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(47.3m)(56.1m)(48.7m)(27.6m)

Depreciation and Amortization

1.3m1.5m1.5m1.3m

Inventories

(2.3m)(6.1m)(1.2m)(92.0k)

Accounts Payable

84.0k470.0k(334.0k)(125.0k)
USDY, 2019

EV/EBIT

-0.2 x

EV/CFO

-0.1 x

Financial Leverage

3.2 x
Show all financial metrics

Avinger Online and Social Media Presence

Embed Graph

Avinger News and Updates

Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $4.…

Avinger to Effect One-for-Ten Reverse Stock Split

REDWOOD CITY, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that the Company will effect a…

Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter

Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019

REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announc…

Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study

OCT Imaging with Pantheris Superior or Equivalent to IVUS on all Parameters

Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device

38% Year-over-Year Pantheris Revenue Growth in First Full Quarter of Launch 38% Year-over-Year Pantheris Revenue Growth in First Full Quarter of Launch
Show more

Avinger Blogs

Study Finds: Black Men and Women have a 30% Higher Risk for Developing Peripheral Artery Disease

Researchers Quantify the Lifetime Risk of Developing Peripheral Artery Disease Based on Race

Diabetes: The Problem of Plaque and Peripheral Artery Disease. What Can You Do?

Diabetes already affects over 170 million people worldwide today, and the number of people living with the illness continues to rise. It should reach the threshold of 366 million by 2030.1 Each year, millions of people suffer from the effects of diabetes complications. Foot ulcers, and a…

Should You Be Tested For PAD?

Answers to these questions will determine if you are at risk for PAD and if a vascular examination will help better assess your vascular health status.

What’s the Connection Between Diabetes and Gangrene?

Many people are unaware of the connection between diabetes and gangrene. However, education on these topics are very important because it can be the different between life and limb.
Show more

Avinger Frequently Asked Questions

  • When was Avinger founded?

    Avinger was founded in 2007.

  • Who are Avinger key executives?

    Avinger's key executives are Jeffrey M. Soinski, Mark Weinswig and Bunty Banerjee.

  • How many employees does Avinger have?

    Avinger has 75 employees.

  • What is Avinger revenue?

    Latest Avinger annual revenue is $7.9 m.

  • What is Avinger revenue per employee?

    Latest Avinger revenue per employee is $105.5 k.

  • Who are Avinger competitors?

    Competitors of Avinger include CardioMech, iSTAR Medical and ControlRad Systems.

  • Where is Avinger headquarters?

    Avinger headquarters is located at 600 Chesapeake Dr, Redwood City.

  • Where are Avinger offices?

    Avinger has an office in Redwood City.

  • How many offices does Avinger have?

    Avinger has 1 office.